Protein Biomarkers For Io Therapeutics - David Duffy, PHD | Quanterix

back to videos & recordings

Protein Biomarkers For Io Therapeutics – David Duffy, PHD

The ultra-sensitive measurement of proteins as biomarkers of Immuno-Oncology therapeutics using Simoa platforms.

Biomarker World Congress and IO Pharma Congress, World Pharma Week, June 2019

Recent Articles

April 1, 2024

Quanterix Scientist Blog Series

December 2, 2024

CTAD 2024 Fuels the Momentum in Advancing Alzheimer’s Disease Detection & Treatment with a Spotlight on Blood-Based Biomarkers

October 3, 2024

Insights from ECTRIMS 2024: Exploring MS Biomarkers and the Role of Quanterix

August 8, 2024

2024 AAIC – A Competitive and Innovative Landscape in Alzheimer’s Research

see all blog posts